Scanning the horizon for high value-add manufacturing science: Accelerating manufacturing readiness for the next generation of disruptive, high-value curative cell therapeutics-Reference-Cited by-同舟云学术

Scanning the horizon for high value-add manufacturing science: Accelerating manufacturing readiness for the next generation of disruptive, high-value curative cell therapeutics

Published:2018-05 Issue:5 Volume:20 Page:759-767
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Hourd Paul,Williams David J.

Funder

UK Regenerative Medicine Platform

Pluripotent Stem Cell Platform

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference41 articles.

1. Regenerative Medicine 2.0;Mason;Regen Med,2007

2. Exploring the state of the science in the field of regenerative medicine: challenges of and opportunities for cellular therapies: proceedings of a Workshop;National Academies of Sciences, Engineering, and Medicine,2017

3. Pluripotent stem cells progressing to the clinic;Trounson;Nat Rev Mol Cell Biol,2016

4. Pluripotent stem cells: the last 10 years;Kimbrel;Regen Med,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human duodenal submucosal glands contain a defined stem/progenitor subpopulation with liver-specific regenerative potential;Journal of Hepatology;2023-01

2. Institutional and infrastructure challenges for hospitals producing advanced therapies in the UK: the concept of ‘point-of-care manufacturing readiness’;Regenerative Medicine;2022-10

3. How to establish infrastructures to achieve more efficient regenerative medicine?;Cell and Tissue Banking;2022-07-24

4. Spatiotemporal readiness is key to preparing regenerative medicine for the clinic;Regenerative Medicine;2021-03

5. A distribution-based approach for determining lot sizes in the filling of human-induced pluripotent stem cells;Regenerative Therapy;2019-12